Newest trends at the CCR Press Conference
In the Harley Academy Press Lounge, the CCR Trends Report was presented to both trade and consumer press. Compiled by former Aesthetics editor Chloé Gronow and co-edited by the editor of Tatler’s annual Beauty & Cosmetic Surgery Guide Francesca Ogiermann-White and Aesthetics journal editor and content manager Shannon Kilgariff, the Trends Report highlights the year’s most innovative advancements and launches.
Exclusive data obtained by Rare: Group revealed that 32% of 25-32-year-olds and 29% of 33-40-year-olds in the UK have had treatment or are considering doing so in the next 12 months. Shockingly, 13% of 16-17-year-olds in the UK have had or are considering treatment in the next year.
The report also announced the launch of several new products and technologies at CCR, including Evolus’ first UK aesthetics conference, showcasing its newly-approved toxin Nuceiva (prabotulinumtoxin A) for use between the eyebrows. New polynucleotide company Plenhyage XL also made its debut, providing injectable treatments to stimulate fibroblasts, encourage cell turnover, improve elasticity, boost collagen production and hydrate skin.
Prollenium’s brand new topical hyaluronidase Topilase, Cutera’s innovative acne treatment device AviClear, AestheticSource’s pigment correcting Cyspera Intensive System, skincare company Evenswiss’ new patented Dermatopoietin technology and Eden Aesthetics’ updated DermaFrac device were all also on show at CCR 2022, among many others.
After presenting the report to members of the press from publications including The Sunday Times, Forbes and HELLO, Kilgariff said, “We created the annual CCR Trends Report to educate both the consumer press and wider aesthetics community about the latest statistics, exciting product launches and developments we are seeing in our specialty. CCR is the perfect stage to showcase this, and we are proud to be a part of the movement to make the aesthetic specialty more accessible to everyone.”